Literature DB >> 991503

Coccidioidomycosis of bone and joints.

R S Bisla, T H Taber.   

Abstract

Sixteen cases of coccidioidomycosis involving bone and joints were treated with Amphotericin B. In all systemic or disseminated cases Amphotericin B should be prescribed. Local Amphotericin B is useful in joints if the disease is limited, and in patients who do not tolerate Amphotericin B by systemic route. If the patient cannot be treated with systemic Amphotericin B, surgical treatment should be directed to remove all possible infected tissue. Patients with a negative skin test and albuminuria in disseminated coccidioidomycosis should be treated with Amphotericin B and passive immune transfer.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 991503

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Coccidioidomycosis: evaluation of parameters used to predict outcome with amphotericin B therapy.

Authors:  M H Hardenbrook; S L Barriere
Journal:  Mycopathologia       Date:  1982-05-22       Impact factor: 2.574

Review 2.  A paradigm for the evaluation and management of spinal coccidioidomycosis.

Authors:  Nikolay L Martirosyan; Jesse M Skoch; Orel Zaninovich; Carmine Zoccali; John N Galgiani; Ali A Baaj
Journal:  Surg Neurol Int       Date:  2015-06-17

Review 3.  The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges.

Authors:  Pei Yee Tiew; Micheál Mac Aogain; Nur A'tikah Binte Mohamed Ali; Kai Xian Thng; Karlyn Goh; Kenny J X Lau; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2020-01-01       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.